Xanthine oxidase-IN-1

CAS No. 1071970-13-2

Xanthine oxidase-IN-1( —— )

Catalog No. M32805 CAS No. 1071970-13-2

Xanthine oxidase-IN-1 is an effective inhibitor of xanthine oxidase with an IC50 value of 6.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 278 In Stock
5MG 328 In Stock
10MG 451 In Stock
25MG 672 In Stock
50MG 885 In Stock
100MG 1144 In Stock
200MG 1544 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Xanthine oxidase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Xanthine oxidase-IN-1 is an effective inhibitor of xanthine oxidase with an IC50 value of 6.5 nM.
  • Description
    Xanthine oxidase-IN-1 is a xanthine oxidase inhibitor extracted from patent WO2008126898A1, page 68, compound example 3, with an IC50 of 6.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Xanthine Oxidase (XAO)
  • Recptor
    Xanthine Oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1071970-13-2
  • Formula Weight
    314.24
  • Molecular Formula
    C16H8F2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(#N)C1=CN(C=2C1=CC(F)=C(F)C2)C3=CC(O)=C(C(O)=O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shimizu K, et al. Preparation of (aza)indole derivatives as xanthine oxidase inhibitors. WO2008126898 A1.
molnova catalog
related products
  • Purpurogallin

    Purpurogallin is a naturally phenol extracted from the plants of Quercus spp.

  • amflutizole

    Amflutizole used for the treatment of gout, and is a Xanthine oxidase inhibitorAmflutizole is a xanthine oxidase inhibitor, inhibits free radical generation in the ischemic/reperfused rat cerebral cortex.

  • Tigulixostat

    Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.